Shaping the Future of Immuno-Oncology

Shaping the Future of Immuno-Oncology

Over the past 15 years, the number and diversity of immunologically-based anticancer agents have increased dramatically. Immuno-oncological therapeutics now include numerous monoclonal antibodies, monoclonal antibody–drug conjugates, bispecific …

(Visited 1 times, 1 visits today)
11
Like
Save

Comments

Comments are disabled for this post.